Cite
Corrigendum to "Cadmium physiologically based pharmacokinetic (PBPK) models for forward and reverse dosimetry: Review, evaluation, and adaptation to the U.S. population" [Toxicol. Lett. 367 (2022) 67-75].
MLA
Pouillot, Régis, et al. “Corrigendum to ‘Cadmium Physiologically Based Pharmacokinetic (PBPK) Models for Forward and Reverse Dosimetry: Review, Evaluation, and Adaptation to the U.S. Population’ [Toxicol. Lett. 367 (2022) 67-75].” Toxicology Letters, vol. 377, Mar. 2023, pp. 14–15. EBSCOhost, https://doi.org/10.1016/j.toxlet.2023.01.011.
APA
Pouillot, R., Santillana Farakos, S. M., Spungen, J., Schaefer, H. R., Flannery, B. M., & Van Doren, J. M. (2023). Corrigendum to “Cadmium physiologically based pharmacokinetic (PBPK) models for forward and reverse dosimetry: Review, evaluation, and adaptation to the U.S. population” [Toxicol. Lett. 367 (2022) 67-75]. Toxicology Letters, 377, 14–15. https://doi.org/10.1016/j.toxlet.2023.01.011
Chicago
Pouillot, Régis, Sofia M Santillana Farakos, Judith Spungen, Heather R Schaefer, Brenna M Flannery, and Jane M Van Doren. 2023. “Corrigendum to ‘Cadmium Physiologically Based Pharmacokinetic (PBPK) Models for Forward and Reverse Dosimetry: Review, Evaluation, and Adaptation to the U.S. Population’ [Toxicol. Lett. 367 (2022) 67-75].” Toxicology Letters 377 (March): 14–15. doi:10.1016/j.toxlet.2023.01.011.